#ICYMI 🚀 Boundless Bio has officially been listed on Nasdaq! 🎉 We’re thrilled to witness this significant milestone as Boundless Bio embarks on its new chapter to revolutionize cancer treatments for patients with oncogene amplified cancers. Congratulations, and we are looking forward to the team propelling groundbreaking advancements in #oncology and paving the way for brighter futures! 🌟 Christine Brennan Lori Hu Sahil Chopra Amanda Chen #NasdaqListing #IPO #CancerResearch #OncogeneCancer #Biotech
A $BOLD step forward for Boundless and patients with oncogene amplified cancer. Today, we celebrate our #IPO at Nasdaq during the opening bell ringing ceremony. We are energized and committed to our pursuit of novel, potentially life-improving treatment options for patients with oncogene amplified cancers. Thank you to our team, partners, investors and supporters – here’s to our next chapter!